Biogen International Neuroscience GmbH
Patent Applications and Registrations
Patent applications and USPTO patent grants for Biogen International Neuroscience GmbH.The latest application filed is for "methods for treating alzheimer's disease".
- Biogen International Neuroscience GmbH - Baar CH
- Biogen International Neuroscience GmbH - Zug N/A CH
| Patent | Date |
|---|---|
| Methods For Treating Alzheimer's Disease App 20220281963 - Boot; Brendon Phillip ; et al. | 2022-09-08 |
| Antibody-dependent cell-mediated phagocytosis assay for reliably measuring uptake of aggregated proteins Grant 11,340,225 - Co , et al. May 24, 2 | 2022-05-24 |
| TDP-43 specific binding molecules Grant 11,091,540 - Nitsch , et al. August 17, 2 | 2021-08-17 |
| Human Anti-Tau Antibodies App 20210238265 - Nitsch; Roger ; et al. | 2021-08-05 |
| Compositions And Methods For Treating Synucleinopathies App 20200377579 - Penner; Natasha ; et al. | 2020-12-03 |
| Methods for treating Alzheimer's disease Grant 10,842,871 - Ferrero , et al. November 24, 2 | 2020-11-24 |
| Methods For Treating Alzheimer's Disease App 20200308259 - Boot; Brendon Phillip ; et al. | 2020-10-01 |
| Human Anti-tau Antibodies App 20200262895A1 - | 2020-08-20 |
| Human anti-alpha-synuclein antibodies Grant 10,703,808 - Weihofen , et al. | 2020-07-07 |
| TDP-43 Specific Binding Molecules App 20200017577 - Nitsch; Roger ; et al. | 2020-01-16 |
| Human Anti-Tau Antibodies App 20190233506 - Nitsch; Roger ; et al. | 2019-08-01 |
| Human Anti-tau Antibodies App 20190169274 - Weinreb; Paul H. ; et al. | 2019-06-06 |
| Anti-alpha synuclein binding molecules Grant 10,301,381 - Weihofen , et al. | 2019-05-28 |
| TDP-43 specific binding molecules Grant 10,259,866 - Nitsch , et al. | 2019-04-16 |
| Use of an Anti-Alpha-Synuclein Antibody to Diagnose an Elevated Level of Alpha-Synuclein in the Brain App 20190094245 - Weihofen; Andreas ; et al. | 2019-03-28 |
| Antibody-dependent Cell-mediated Phagocytosis Assay For Reliably Measuring Uptake Of Aggregated Proteins App 20190079077 - Co; Carl ; et al. | 2019-03-14 |
| Human Anti-Alpha-Synuclein Antibodies App 20180371065 - Weihofen; Andreas ; et al. | 2018-12-27 |
| Anti-Alpha Synuclein Binding Molecules App 20180355027 - Weihofen; Andreas ; et al. | 2018-12-13 |
| Methods For Treating Alzheimer's Disease App 20180333487 - Ferrero; James L. ; et al. | 2018-11-22 |
| Anti-alpha synuclein binding molecules Grant 9,975,947 - Weihofen , et al. May 22, 2 | 2018-05-22 |
| Human anti-alpha-synuclein antibodies Grant 9,896,504 - Weihofen , et al. February 20, 2 | 2018-02-20 |
| Use of an Anti-Alpha-Synuclein Antibody to Diagnose an Elevated Level of Alpha-Synuclein in the Brain App 20180011112 - Weihofen; Andreas ; et al. | 2018-01-11 |
| Human Anti-Tau Antibodies App 20180002409 - Nitsch; Roger ; et al. | 2018-01-04 |
| Human Anti-tau Antibodies App 20170369560 - Weinreb; Paul H. ; et al. | 2017-12-28 |
| Anti-Alpha Synuclein Binding Molecules App 20170233463 - Weihofen; Andreas ; et al. | 2017-08-17 |
| TDP-43 Specific Binding Molecules App 20170152308 - Nitsch; Roger ; et al. | 2017-06-01 |
| Human anti-tau antibodies Grant 9,605,059 - Nitsch , et al. March 28, 2 | 2017-03-28 |
| Human anti-tau antibodies Grant 9,598,484 - Weinreb , et al. March 21, 2 | 2017-03-21 |
| TDP-43 specific binding molecules Grant 9,587,014 - Nitsch , et al. March 7, 2 | 2017-03-07 |
| Anti-.alpha. synuclein binding molecules Grant 9,580,493 - Weihofen , et al. February 28, 2 | 2017-02-28 |
| Human Anti-alpha-synuclein Antibodies App 20160244515 - Weihofen; Andreas ; et al. | 2016-08-25 |
| Genetic And Image Biomarkets Associated With Decline In Cognitive Measures And Brain Glucose Metabolism In Populations With Alzheimer's Disease Or Those Susceptible To Developing Alzheimer's Disease App 20160177390 - Feng; Sheng ; et al. | 2016-06-23 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 